translocation RCC

Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinoma

By Sharon Deveson Kell|2022-08-23T14:44:26+00:0023 Aug 2022|Drug treatments|

MiT family translocation renal cell carcinoma is a rare and [...]

Comments Off

EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

By Sharon Deveson Kell|2022-04-26T08:39:32+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Comments Off

Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

By Sharon Kell|2020-04-06T10:00:28+00:006 Apr 2020|Uncategorized|

In this video interview from Practice Update, Dr Brad McGregor [...]

Comments Off

Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma

By Sharon Kell|2020-03-25T09:40:03+00:0025 Mar 2020|Uncategorized|

Nivolumab alone and in combination with ipilimumab is used for [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org